G&E Herbal Biotechnology Co., Ltd.

Taipei Exchange 4911.TWO

G&E Herbal Biotechnology Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 16.63

G&E Herbal Biotechnology Co., Ltd. Price to Sales Ratio (P/S) is 16.63 on January 14, 2025, a -2.32% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • G&E Herbal Biotechnology Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 18.90 on December 09, 2024, which is 13.65% above the current Price to Sales Ratio (P/S).
  • G&E Herbal Biotechnology Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 15.33 on August 06, 2024, which is -7.79% below the current Price to Sales Ratio (P/S).
  • G&E Herbal Biotechnology Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 16.92.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
Taipei Exchange: 4911.TWO

G&E Herbal Biotechnology Co., Ltd.

CEO Mr. Kou-Wha Kou Ph.D.
IPO Date March 21, 2011
Location
Headquarters No.92, Keji 5th Road
Employees 37
Sector Health Care
Industries
Description

G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products. In addition, it is developing Solarise injection for the treatment of gynecologic, head, and neck cancer; Apocin capsule to treat non-small cell lung cancer; and SR-T100 Gel for the treatment of common and genital warts. Further, the company manufactures technology development for various dietary supplements, as well as provides technical advisory services to other biotechnology organizations. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email